Generic Ozempic is coming to Canada. This company wants to make it

A Canadian pharmaceutical company, headed by two former executives with the company behind Ozempic, hopes to make a generic version of the weight-loss drug in Edmonton. Data protections on the GLP-1 receptor, semaglutide, expired in January.

The National is the flagship of CBC News, showcasing award-winning journalism from across Canada and around the world. Led by Chief Correspondent Adrienne Arsenault, our team of trusted reporters helps you make sense of the world, wherever you are.

Subscribe to get the latest news daily, and watch live starting at 9 p.m. ET.
https://www.youtube.com/user/CBCTheNational?sub_confirmation=1

More from CBC News | https://www.cbc.ca/news